Caris Life Sciences Director Fredrickson Receives RSU Award

What Happened
David Paul Fredrickson, a director of Caris Life Sciences, was granted 13,192 restricted stock units (RSUs) on August 14, 2026. The Form 4 reports an acquisition (code A) of 13,192 shares at an acquisition price of $0.00 (total reported value $0), reflecting an award rather than a market purchase.

Key Details

• Transaction date: 2026-08-14 (reported on Form 4 for the same date).
• Transaction type/code: Grant/award (A) — 13,192 RSUs at $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: RSUs vest in accordance with the applicable grant agreement (may be time- or performance‑based).
• Timeliness: Filing covers the transaction date listed; no late filing indicated in the provided information.

Context
RSUs are awards that convert into company shares only if and when vesting conditions are met; they are not an immediate open‑market purchase or sale. Because this is an equity award (not a purchase or sale), it should be viewed as a compensation/retention action rather than a direct bullish or bearish trading signal.